睿兽Pro . 以下文章来源于睿兽Pro ，作者Bestla 创业邦旗下横跨一二级市场的科创数据平台。实时投资数据、追踪产业创新。找数据、做分析、链资 源，就上睿兽分析。 全球投融资周报 睿兽分析每周整理当周最值得关注的国内外热门投融资事件，帮助大家及时了解全球市场动向。 一级市场投融资概览 根据睿兽分析监测数据，本周国内一级市场披露的融资事件47个， 与上周相比减少48个， 其中已披 露融资金额的事件27个， 总融资规模为56.76亿元人民币， 平均融资金额为2.10亿元人民币。 行业分布 从融资事件数量来看，本周医疗健康、人工智能、智能制造领域融资最活跃。 分别为医疗健康9个、 人工智能8个、智能制造8个。 从已披露金额事件的融资规模来看，企业服务最高，融资总规模约为26.07亿元人民币。 其中科技产 业投资及管理服务提供商「新微科技」完成25.7亿人民币C轮融资。 新微科技集团是一家专注于集成电路行业的高科技产业集团，致力于成为全球集成电路产业的重要推 动者。集团深耕特色工艺研究，凭借丰富的科技成果转化经验，形成了覆盖集成电路材料、设备、 FAB、先进封测、软件、器件及应用的完整产业链条。 其次是智能制 ...

截止到2025年11月，8个主流厂商合计推出了409个大模型，其中，单模态、多模态和全模态占比分别为 61.4%、36.7%、1.9%。这当中，多模态交互已经逐渐成为主流，"多模态输入"到"单模态输出"占比高 达73.3%。 在体系化和生态化竞争的驱动下，应用落地层面呈现出百花齐放的格局，从7月到11月，超过200款AI 应用面世，其中，AI应用插件、PC网页端、AI原生APP占比分别达到81.5%、10.7%、7.8%；应用方向 上，深度洞察用户个性化需求与场景痛点的垂直应用成为突破口，例如，AI图像处理、AI专业顾问、 AI效率办公、AI社交互动、AI文案写作占比分别达到24.9%、18.5%、6.8%、5.9%、5.9%。 此外，从2025年7月到11月，短短五个月里，产业链完成了186起投融资，金额达到336.7亿元，较上半 年增加20.8%。 凤凰网科技讯 12月23日，QuestMobile数据显示，截至最新统计周期（12.08-12.14），AI原生APP活跃 用户榜单已经发生了巨大变化，其中，豆包、DeepSeek、元宝仍位居前三，周活跃分别为1.55亿、8156 万、2084万；蚂蚁阿福、千 ...

广州科创大赛十年促参赛企业获投融资超504.84亿元 当日，由广州市科学技术局主办的广州科技创新创业大赛2025总决赛暨INNOPLUS大湾区科创嘉年华活 动在广州举行。活动邀请10年来参赛的知名科创者分享企业成长历程，并为今年获一等奖的企业颁奖， 数十家投资机构代表到场，并举行广州科技创新创业大赛企业授信签约仪式等活动。 据介绍，该大赛十年间吸引超3.5万家科技企业参赛，累计促成近千家参赛企业获得投融资超504.84亿 元、1800家企业获得160亿元银行授信。2025年，今届大赛累计吸引超1500家企业及团队报名参赛，细 分19个赛道和港澳台赛，推动扩大科创生态圈、定准产业链，提升企业创新要素对接的精准度。 广州市科技局局长谢明表示，通过大赛，更多广州优秀的初创企业获得了市场和投资界关注。"今天举 办这场活动，是希望能让更多优秀企业站在广州创新舞台的'C位'。在供给侧，广州的优质科创成果非 常多，我们需要更多纽带，让创新成果更好地转化为产业发展的动力。"他说。 谢明介绍，此次活动共邀请到全国逾60家知名投资机构，目前，广州正打造200亿元的科技创新基金， 基金未来将联动更多投资机构共同投早、投小、投硬科技 ...

以下文章来源于睿兽Pro ，作者Bestla 睿兽Pro . 创业邦旗下横跨一二级市场的科创数据平台。实时投资数据、追踪产业创新。找数据、做分析、链资 源，就上睿兽分析。 全球投融资周报 睿兽分析每周整 理当周最 值得关注的国内外热门投融资事件，帮助大家及时了解全球市场动向。 一级市场投融资概览 根据睿兽分析监测数据，本周国内一级市场披露的融资事件67个，与上周相比增加10个， 其中已披 露融资金额的事件32个，总融资规模为41.85亿元人民币，平均融资金额为1.31亿元人民币。 行业分布 从融资事件数量来看，本周智能制造、医疗健康、人工智能领域融资最活跃。分别为智能制造13个、 医疗健康12个、人工智能10个。 从已披露金额事件的融资规模来看，医疗健康最高，融资总规模约为9.30亿元人民币。其中抗肿瘤药 物研发商 「康源博创」 获近2.5亿人民币 B轮融资。 康源博创成立于2017年，是一家专注于生物科技领域的高新技术企业，提供包括体外和体内药理学 研究、细胞系工程、治疗靶点识别及抗体发现等创新服务。公司利用其独特的专有资产，如3000多 种工程细胞系、双特异性及三特异性抗体发现小鼠模型等，为药物研发提供定 ...

将投中网设为"星标⭐"，第一时间收获最新推送 新消费赛道，黄金珠宝成新宠。 上周，专注于花丝镶嵌和黄金技艺的高端黄金珠宝品牌寶蘭宣布完 成上亿元人民币的A轮融资。本轮融资由挑战者创投领投，开云集团和顺为资本跟投。此外，黄金手 工艺术品牌琳朝珠宝已完成亿元级战略投资，独家投资方为日初资本。 硬科技赛道，地方国资成主导。 上周，湖南揽月机电科技有限公司顺利完成数亿元A+轮融资。本轮 融资由成都科创投领投，国信资本、湘江国投等多家机构跟投。此外，恩力动力完成数亿元B+轮融 资。绿动资本与北京市绿色能源和低碳产业投资基金、北京市新材料产业投资基金共同对恩力动力进 行战略投资。 大健康赛道，创新药进入"深水区"。 上周，凯思凯迪宣布成功完成近 3 亿元 B 轮融资。本轮融资 由国投先导领投，浦东创投集团、张江集团、阳光融汇、沃美达、临创蓝湾联合参投，老股东富汇资 本持续加码。此外，博致生物（Proviva Therapeutics）宣布完成逾3000万美元的A+轮融资。本 轮融资由奥博资本（OrbiMed）领投，多家著名的头部机构跟投，包括汉康资本（Hankang）、红 杉中国及某全球知名产业基金。 据投中网不完全统计 ...

Core Insights - The event held in Jiangmen City aims to promote investment and financing opportunities, highlighting the importance of financial resources in industrial development [1][3][5] Group 1: Event Overview - The 2025 Guangdong Local Investment and Financing Exchange Conference was co-hosted by Jiangmen Municipal Government and various financial institutions, attracting around 180 representatives from listed companies, financial institutions, and local state-owned enterprises [1][3] - Notable experts, including members from the Chinese Academy of Social Sciences and the National Development and Reform Commission, delivered keynote speeches on economic trends and investment strategies [1][5] Group 2: Government and Institutional Perspectives - Jiangmen's Vice Mayor emphasized the city's commitment to high-quality development, aiming to attract quality enterprises and financial institutions to enhance industrial growth [3][5] - The Jiangmen State-owned Assets Supervision and Administration Commission aims to transform state-owned enterprises into "industrial operators" and "ecological builders" to support project implementation [3][5] Group 3: Financial Sector Contributions - Caida Securities highlighted its role as a state-owned financial institution, focusing on serving national development strategies and local economic construction [5][6] - The company aims to empower regional high-quality development by acting as a "capital enabler," "investment connector," and "decision-making advisor" [5][6] Group 4: Expert Insights - Experts discussed macroeconomic trends and the importance of optimizing income distribution and investment focus to stimulate endogenous economic growth [5][6] - Recommendations were made for local governments to enhance investment structures and foster growth momentum for sustainable high-quality development [5][6] Group 5: Local Economic Development - The conference included presentations on Jiangmen's business environment and investment opportunities, showcasing local resources and projects [6] - Business leaders shared their experiences and outlook on investing in Jiangmen, emphasizing the city's potential for growth [6]

Core Insights - The 2025 Xiamen University Torch Entrepreneurship Growth Camp and Nanchang Entrepreneurship Camp is organized by Xiamen University and various local institutions, aiming to support innovative startups through training and investment opportunities [1][3]. Group 1: Event Overview - The event will take place on November 22 at Tianyuan Hotel in Xiamen, featuring over 30 selected entrepreneurs who will present their projects after undergoing a comprehensive training program [4]. - The event aims to create a platform for entrepreneurs and investors to connect, fostering collaboration and innovation in the tech sector [3][5]. Group 2: Entrepreneurial Support - The "Technology Innovation Project Exhibition" will facilitate direct connections between nearly 100 investment institutions and entrepreneurs, focusing on their immediate needs and long-term development plans [5]. - Industry experts will be invited to discuss key topics such as technology innovation and investment trends, helping entrepreneurs identify challenges and opportunities in the market [5]. Group 3: Engagement and Activities - The event will include performances by industry leaders and surprise giveaways to enhance the atmosphere and engagement [6]. - Registration for the event is open, encouraging participation from entrepreneurial projects and financial service institutions [8].

Core Viewpoint - The article provides an overview of the latest trends in investment and financing activities in the domestic market, highlighting key sectors and significant financing events. Group 1: Investment Overview - This week, there were 109 disclosed financing events in the domestic primary market, an increase of 12 compared to the previous week. Among these, 36 events disclosed financing amounts, totaling 4.786 billion RMB, with an average financing amount of 133 million RMB [7]. - The most active sectors in terms of financing events were intelligent manufacturing, artificial intelligence, and healthcare, with 21, 16, and 13 events respectively [9]. Group 2: Sector Highlights - In terms of disclosed financing amounts, artificial intelligence led with a total financing scale of approximately 1.055 billion RMB. Notably, the bionic robot developer "Wubai Intelligent" secured nearly 500 million RMB in Series A financing [9][10]. - The healthcare sector followed with a disclosed financing total of 670 million RMB, where the medical isotope developer "Nuclear Element Innovation" received 430 million RMB in Series A financing [10]. Group 3: Regional Distribution - The disclosed financing events were primarily concentrated in Jiangsu, Zhejiang, and Guangdong, with Jiangsu reporting 24 events, Zhejiang 19 events, and Guangdong 18 events [14][17]. Group 4: Stage Distribution - The stage distribution of the disclosed financing events showed that 81 were early-stage, 24 were growth-stage, and 4 were late-stage [17]. Group 5: Major Financing Events - The article mentions significant financing events, including the acquisition of 70% of the semiconductor packaging materials manufacturer "Huawei Electronics" by Huahai Chengke for 1.12 billion RMB [35][37]. Group 6: Active Investment Institutions - The most active investment institutions this week included CRRC Capital with 4 investment events, Shenzhen Capital Group with 3, and Legend Capital with 2 [24]. Group 7: IPO Highlights - A total of 8 companies were monitored for IPOs this week, with the highest market capitalization being "Sany Heavy Industry" at 212.898 billion HKD. All listed companies had previously received VC/PE or CVC investments [28][29].

Core Insights - The 10th Pharmaceutical Innovation and Investment Conference will be held on October 26-27, 2025, in Nanjing, focusing on global pharmaceutical frontiers and capital trends, gathering top minds in the pharmaceutical innovation and investment fields [1][2]. Conference Information - The conference will take place at Fengda International Hotel, Nanjing, and will cover multiple thematic forums including innovative drug research and development, clinical research, cell and gene therapy, investment mergers and acquisitions, capital markets, and commercial insurance policies [2]. - The agenda includes various sub-forums such as cell and gene therapy, weight loss innovation, clinical data, anti-tumor new drugs, and international roadshows, ensuring comprehensive coverage of the pharmaceutical industry [3][4]. Key Topics - The conference will address core challenges and development trends in the pharmaceutical industry, emphasizing internationalization, investment financing, and regulatory policies, with a focus on the synergy between basic medical insurance and commercial health insurance [5]. - Discussions will include the strategies of Chinese innovative pharmaceutical companies in global markets, particularly in terms of licensing, mergers, and new investment trends [5][6]. Expert Participation - The conference will feature senior experts, clinical specialists, industry leaders, and frontline investors who will share insights on breakthrough technologies, practical experiences in investment mergers, and policy interpretations [4][6]. - Notable speakers include leaders from prestigious institutions and companies, contributing to discussions on the construction of innovative ecosystems and cross-sector collaboration [4][6]. Forum Structure - The conference will be structured around multi-dimensional forums designed to promote deep dialogue and knowledge sharing across clinical, industrial, capital, and policy fields, with three core discussion directions: global strategic layout, capital collaborative innovation, and market trend outlook [6].

Core Viewpoint - The State Council has officially approved the "Open Innovation Development Plan for the Entire Biopharmaceutical Industry Chain in the China (Jiangsu) Pilot Free Trade Zone," emphasizing the importance of the biopharmaceutical industry as a leading sector for the city [1] Group 1: Strategic Development - The city government is committed to maintaining strategic determination and patience while seizing opportunities and actively promoting the biopharmaceutical industry [1] - The focus is on high-quality development of the biopharmaceutical sector, with an emphasis on long-term vision and sustained efforts [1] Group 2: Policy Implementation - There is a call for increased policy research tailored to Suzhou's actual conditions, with detailed implementation plans to enhance policy awareness and facilitate direct benefits for enterprises [1] - The aim is to create a world-influential biopharmaceutical industry cluster and a more internationally competitive innovation development hub [1] Group 3: Financial Support and Innovation - Financial institutions are encouraged to increase investment and financing in the biopharmaceutical sector, establishing a regular discussion mechanism to foster patient and long-term capital [1] - There is a push for innovative insurance products to improve the accessibility of innovative drugs [1] Group 4: Business Environment Optimization - Continuous optimization of the business environment is prioritized, with efforts to enhance review and approval services to create a top-tier industrial development environment in the country [1]